538 related articles for article (PubMed ID: 26509589)
1. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.
Rodríguez-Romo R; Benítez K; Barrera-Chimal J; Pérez-Villalva R; Gómez A; Aguilar-León D; Rangel-Santiago JF; Huerta S; Gamba G; Uribe N; Bobadilla NA
Kidney Int; 2016 Feb; 89(2):363-73. PubMed ID: 26509589
[TBL] [Abstract][Full Text] [Related]
2. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
[TBL] [Abstract][Full Text] [Related]
3. Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury.
Molinas SM; Cortés-González C; González-Bobadilla Y; Monasterolo LA; Cruz C; Elías MM; Bobadilla NA; Trumper L
Nephron Exp Nephrol; 2009; 112(1):e10-9. PubMed ID: 19342869
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury.
Barrera-Chimal J; Pérez-Villalva R; Rodríguez-Romo R; Reyna J; Uribe N; Gamba G; Bobadilla NA
Kidney Int; 2013 Jan; 83(1):93-103. PubMed ID: 23014458
[TBL] [Abstract][Full Text] [Related]
5. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
[TBL] [Abstract][Full Text] [Related]
6. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
[TBL] [Abstract][Full Text] [Related]
7. Urinary angiotensinogen predicts progressive chronic kidney disease after an episode of experimental acute kidney injury.
Cui S; Wu L; Feng X; Su H; Zhou Z; Luo W; Su C; Li Y; Shi M; Yang Z; Cao W
Clin Sci (Lond); 2018 Oct; 132(19):2121-2133. PubMed ID: 30224346
[TBL] [Abstract][Full Text] [Related]
8. Ageing reduces angiotensin II type 1 receptor antagonism mediated pre-conditioning effects in ischemic kidneys by inducing oxidative and inflammatory stress.
Ogbadu J; Singh G; Gupta K; Mehra K; Sen P
Exp Gerontol; 2020 Jul; 135():110892. PubMed ID: 32119995
[TBL] [Abstract][Full Text] [Related]
9. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
Lok SWY; Yiu WH; Zou Y; Xue R; Li H; Ma J; Chen J; Chan LYY; Lai KN; Tang SCW
Nephrol Dial Transplant; 2023 Sep; 38(10):2232-2247. PubMed ID: 36914214
[TBL] [Abstract][Full Text] [Related]
10. Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism.
Mehrotra P; Patel JB; Ivancic CM; Collett JA; Basile DP
Kidney Int; 2015 Oct; 88(4):776-84. PubMed ID: 26200947
[TBL] [Abstract][Full Text] [Related]
11. Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury.
Lai CF; Lin SL; Chiang WC; Chen YM; Wu VC; Young GH; Ko WJ; Kuo ML; Tsai TJ; Wu KD
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F581-92. PubMed ID: 24920753
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into acute kidney injury-chronic kidney disease continuum and the role of renin-angiotensin system.
Chou YH; Huang TM; Chu TS
J Formos Med Assoc; 2017 Sep; 116(9):652-659. PubMed ID: 28615146
[TBL] [Abstract][Full Text] [Related]
13. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.
Picken M; Long J; Williamson GA; Polichnowski AJ
Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease: Role of Oxidative Stress.
Lattenist L; Lechner SM; Messaoudi S; Le Mercier A; El Moghrabi S; Prince S; Bobadilla NA; Kolkhof P; Jaisser F; Barrera-Chimal J
Hypertension; 2017 May; 69(5):870-878. PubMed ID: 28320854
[TBL] [Abstract][Full Text] [Related]
16. Mild ischemic injury leads to long-term alterations in the kidney: amelioration by spironolactone administration.
Barrera-Chimal J; Pérez-Villalva R; Ortega JA; Sánchez A; Rodríguez-Romo R; Durand M; Jaisser F; Bobadilla NA
Int J Biol Sci; 2015; 11(8):892-900. PubMed ID: 26157344
[TBL] [Abstract][Full Text] [Related]
17. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
18. Acute Kidney Injury to Chronic Kidney Disease Transition.
Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition.
Polichnowski AJ; Griffin KA; Licea-Vargas H; Lan R; Picken MM; Long J; Williamson GA; Rosenberger C; Mathia S; Venkatachalam MA; Bidani AK
Am J Physiol Renal Physiol; 2020 May; 318(5):F1086-F1099. PubMed ID: 32174143
[TBL] [Abstract][Full Text] [Related]
20. Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia.
Tokuyama H; Kelly DJ; Zhang Y; Gow RM; Gilbert RE
Nephron Physiol; 2007; 106(3):p54-62. PubMed ID: 17570949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
